Noma: a reappraisal in Western countries - are HIV-negative immunocompetent adult patients safe?

Mascitti, M; Barlattani, A; Togni, L; Sampalmieri, F; Favia, G; Lo Muzio, L; Santarelli, A

Mascitti, M; Barlattani, A; Togni, L; Sampalmieri, F; Favia, G; Lo Muzio, L; Santarelli, A.

Afiliação

Mascitti M; Department of Clinical Specialistic and Dental Sciences, Marche Polytechnic University, Ancona, Italy.
Barlattani A; Department of Clinical Sciences and Translational Medicine, Tor Vergata University, Roma, Italy.
Togni L; Department of Clinical Specialistic and Dental Sciences, Marche Polytechnic University, Ancona, Italy.
Sampalmieri F; Department of Clinical Specialistic and Dental Sciences, Marche Polytechnic University, Ancona, Italy.
Favia G; Department of Interdisciplinary Medicine, Complex Operating Unit of Odontostomatology, "Aldo Moro" University, Bari, Italy.
Lo Muzio L; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Santarelli A; Department of Clinical Specialistic and Dental Sciences, Marche Polytechnic University, Ancona, Italy.

J Biol Regul Homeost Agents ; 33(3): 957-961, 2019.

Article em En | MEDLINE | ID: mdl-31184103

ABSTRACT

ABSTRACT

Noma is an ancient Greek term referring to a gangrenous disease that destroys soft and hard tissues of oral and perioral structures. This disease has been known since ancient times and persisted in Europe until World War 2, while in the present day it is almost exclusively found in sub-Saharan Africa.

Assuntos

Noma/epidemiologia; Europa (Continente); HIV; Humanos

Palavras-chave

Cancrum oris; immunocompetent patient; noma; type 2 Diabetes mellitus

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Noma Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links